Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy
Resource
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 108(42), 17275-17280
Journal
Proceedings of the National Academy of Sciences
Pages
17275-17280
Date Issued
2011
Date
2011
Author(s)
Wu, Tai-Na
Lin, Kun-Hsien
Chang, Ya-Jen
Huang, Jing-Rong
Cheng, Jing-Yan
Yu, Alice L.
Wong, Chi-Huey
Abstract
Invariant natural killer T cell (NKT) cells (iNKT cells) produce both T-helper 1 (Th1) and T-helper 2 cytokines in response to α- Galactosylceramide (α-GalCer) stimulation and are thought to be the important effectors in the regulation of both innate and adaptive immunity involved in autoimmune disorders, microbial infections, and cancers. However, the anticancer effects of α-GalCer were limited in early clinical trial. In this study, several analogs of α-GalCer, containing phenyl groups in the lipid tails were found to stimulate murine and human iNKT cells to secrete Th1-skewed cytokines and exhibit greater anticancer efficacy in mice than α-GalCer. We explored the possibility of different Vβ usages of murine Vα14 iNKT or human Vα24 iNKT cells, accounting for differential cytokine responses. However, T-cell receptor Vβ analysis revealed no significant differences in Vβ usages by α-GalCer and these phenyl glycolipid analogs. On the other hand, these phenyl glycolipids showed greater binding avidity and stability for iNKT T-cell receptor when complexed with CD1d. These findings suggest that CD1d-phenyl glycolipid complexes may interact with the same population of iNKT cells but with higher avidity and stability to drive Th1 polarization. Thus, this study provides a key to the rational design of Th1 biased CD1d reactive glycolipids in the future.
Subjects
Cancer immunotherapy; Immune-modulating activity; Interaction; Structure
SDGs
Other Subjects
alpha galactosylceramide; CD1d antigen; T lymphocyte receptor beta chain; ternary complex factor; antineoplastic activity; article; binding affinity; cancer growth; cell polarity; chemical structure; controlled study; cytokine production; cytokine response; human; human cell; immunomodulation; in vitro study; in vivo study; mouse; natural killer cell; nonhuman; priority journal; Th1 cell; Th2 cell; Animals; Antigens, CD1d; Cell Line, Tumor; Chemokines; Cytokines; Female; Galactosylceramides; Glycolipids; Humans; Immunotherapy; Ligands; Lymphocyte Activation; Macromolecular Substances; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Natural Killer T-Cells; Neoplasms, Experimental; Receptors, Antigen, T-Cell, alpha-beta; Th1 Cells; Murinae; Mus
Type
journal article
File(s)![Thumbnail Image]()
Loading...
Name
48.pdf
Size
23.17 KB
Format
Adobe PDF
Checksum
(MD5):c8994c124c202d5d670db4fa08b994c4